Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 51

Daily Deal Round Up: May 10, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 10, 2022

Daily Deal Round Up: May 9, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 9, 2022

Daily Deal Round Up: May 6, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 6, 2022

GBT reaches unicorn status with $150m series A

Fresh funding for the EV battery company comes as Chinese automotive players are ramping up mobility investment efforts.

May 6, 2022

Porsche leads Group14’s $400m series C

Automaker Porsche has led the SK Materials, Amperex, Showa Denko Cabot and BASF-backed EV battery technology provider’s fresh round to help advance the EV industry.

May 5, 2022

Daily Deal Round Up: May 4, 2022

The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

May 4, 2022

VisionNav visualises $80m

Meituan co-led the unmanned forklift producer’s series C-plus round, which came seven months after a first close that featured ByteDance and Lenovo.

May 3, 2022

Daily Deal Round Up: April 29, 2022

Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.

Apr 29, 2022

Daily Deal Round Up: April 28, 2022

Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

Apr 28, 2022

Daily Deal Round Up: April 27, 2022

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Apr 27, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here